Stoke Therapeutics logo

Stoke Therapeutics

Stoke Therapeutics is a biopharma company that develops RNA-targeted treatments for severe genetic diseases.

3

Funding Rounds

$235.1m

Money raised

Overview

Stoke Therapeutics is a biopharma company that develops RNA-targeted treatments for severe genetic diseases.

Funding series

Funding Series Analysis

The company Stoke Therapeutics has raised a total of $40m in funding over 3 rounds.

Key Insights:

  • Stoke Therapeutics Series A round, January 2017: $40m
  • Stoke Therapeutics Venture round, November 2020: $105.1m
  • Stoke Therapeutics funding round, October 2018: $90m
Stoke Therapeutics logo
Stoke Therapeutics Series A round, January 2017 $40m
Stoke Therapeutics logo
Stoke Therapeutics Venture round, November 2020 $105.1m
Stoke Therapeutics logo
Stoke Therapeutics funding round, October 2018 $90m